Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 673193, 15 pages
http://dx.doi.org/10.1155/2013/673193
Review Article

Evaluation of the Add-On Effect of Chinese Patent Medicine for Patients with Stable or Unstable Angina: A Systematic Review and Meta-Analysis

1Division of Epidemiology, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Prince of Wales Hospital, 4/F School of Public Health Building, Shatin, New Territories, Hong Kong
2Shenzhen Municipal Key Laboratory for Health Risk Analysis, Shenzhen Research Institute, The Chinese University of Hong Kong, 10 Yuexing Erdao, Nanshan District, Shenzhen, Guangdong 518000, China
3The Hong Kong Branch of the Chinese Cochrane Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Received 28 April 2013; Revised 8 October 2013; Accepted 15 October 2013

Academic Editor: Lixing Lao

Copyright © 2013 Chen Mao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Henderson and N. O'Flynn, “Management of stable angina: summary of NICE guidance,” Heart, vol. 98, no. 6, pp. 500–507, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. H. H. Gray, R. A. Henderson, M. A. de Belder, S. R. Underwood, and A. J. Camm, “Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance,” Heart, vol. 96, no. 20, pp. 1662–1668, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. F. C. Lampe, R. W. Morris, M. Walker, A. Gerald Shaper, and P. H. Whincup, “Trends in rates of different forms of diagnosed coronary heart disease, 1978 to 2000: prospective, population based study of British men,” British Medical Journal, vol. 330, no. 7499, pp. 1046–1049, 2005. View at Google Scholar · View at Scopus
  4. H. Hemingway, C. Langenberg, J. Damant, C. Frost, K. Pyörälä, and E. Barrett-Connor, “Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries,” Circulation, vol. 117, no. 12, pp. 1526–1536, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Sekhri, G. S. Feder, C. Junghans, H. Hemingway, and A. D. Timmis, “How effective are rapid access chest pain clinics? Prognosis of incident angina and non-cardiac cnest pain in 8762 consecutive patients,” Heart, vol. 93, no. 4, pp. 458–463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. H. S. Javitz, M. M. Ward, J. B. Watson, and M. Jaana, “Cost of illness of chronic angina,” The American Journal of Managed Care, vol. 10, supplement, no. 11, pp. S358–S369, 2004. View at Google Scholar · View at Scopus
  7. J. A. Spertus, P. Jones, M. McDonell, V. Fan, and S. D. Fihn, “Health status predicts long-term outcome in outpatients with coronary disease,” Circulation, vol. 106, no. 1, pp. 43–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. R. S. Wright, J. L. Anderson, and C. D. Adams, “2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Journal of the American College of Cardiology, vol. 60, no. 7, pp. 645–681, 2012. View at Google Scholar · View at Scopus
  9. J.-L. Tang, B.-Y. Liu, and K.-W. Ma, “Traditional Chinese medicine,” The Lancet, vol. 372, no. 9654, pp. 1938–1940, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H.-J. Wang, Y.-W. Huang, and J. Sun, “Effect of tongxinluo capsule on function of vascular endothelium in patients with unstable angina pectoris,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 23, no. 8, pp. 587–589, 2003. View at Google Scholar · View at Scopus
  11. C. Chen, “Effect of Scolopendra extract in experiment onrabbit heart,” Chinese Medicine Pharmacology and Clinical Practice, vol. 1, no. 1, pp. 124–125, 1985. View at Google Scholar
  12. J. Zhai, “The clinical control study of Fufangdanshen dropping pills in the treatment of coronary artery disease Angina pectoris,” Chinese Primary Health Care, vol. 23, no. 7, pp. 92–93, 2009. View at Google Scholar
  13. S. He, J. Chen, and L. Zhu, “The Effect of Fufangdanshen on hemorheology in patients with Stable Angina,” Clinical Journal of Hemorrhage, vol. 18, no. 1, pp. 92–95, 2008. View at Google Scholar
  14. X. H. Liu, “Shengmai capsules for the treatment of unstable angina,” China Medical Herald, vol. 6, no. 34, pp. 147–148, 2009. View at Google Scholar
  15. D. Zhao, “Clinical evaluation of treatment of unstable Angina pectoris (UAP) by metoprolol succinate sunstanedrelease tablets combined with Shexiangbaoxin pill,” China Practical Medicine, vol. 5, no. 23, pp. 82–83, 2010. View at Google Scholar
  16. J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0, The Cochrane Collaboration, 2011, http://handbook.cochrane.org/.
  17. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” British Medical Journal, vol. 339, Article ID b2535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Qi, J. G. Liu, J. Du, and F. Wang, “Evaluating the effectiveness of Shexiangbaoxinwang for the treatment of effort angina pectoris with 99m|TC-MIBI SPECT,” Shanghai Medicine, vol. 12, no. 12, pp. 24–25, 1996. View at Google Scholar
  19. C. Liu and P. Gong, “The effectiveness of Shengmai capsule for the treatment of stable angin,” Journal of Liaoning College of Traditional Chinese Medicine, vol. 5, no. 4, p. 263, 2003. View at Google Scholar
  20. J. Shen, Q. Yan, Z. Li, and Y. Zhang, “The medium and long-term outcomes of Danshen drop pill for angina pectoris,” Heilongjiang Medicine, vol. 6, no. 11, pp. 11–12, 2003. View at Google Scholar
  21. D. Yu, L. Jia, and Y. Yuan, “The effectiveness of Xuezhikang for angina and myocardial ischemia patients with normal cholesterol level,” Chinese Journal of Cardiovascular Rehabilitation Medicine, vol. 15, no. 2, pp. 181–184, 2006. View at Google Scholar
  22. Z. Hou, “The effectiveness of Danhong injection for the treatment of 123 patients diagnosed with stable angina,” Central Plains Medical Journal, vol. 34, no. 11, pp. 81–82, 2007. View at Google Scholar
  23. J. Yao, Y. Zhu, Y. Feng, and L. Yi, “The effectiveness of Aoweixin for treatment of famale amgina patients,” Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, vol. 5, no. 9, 2007. View at Google Scholar
  24. L. Gao, Y. Li, and K. Chen, “Effects of supplementing Qi and activating blood circulation method on plate let aggregation rate, adhesion rate and thromboxane B2 level in patients with atable angina P ector is and intolerable to aspirin,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 29, no. 7, p. 1081, 2008. View at Google Scholar
  25. H. Li, “The effectiveness of Dengzhanshengmai capsule for the prevention of recrudesce of stable angina in 100 patients,” Guangdong Medical Journal, vol. 29, no. 7, p. 1081, 2008. View at Google Scholar
  26. X. Ye, “The Combiantion of Xinyuan capsule and Simvastatin for the Secondary prevention of angina,” China Modern Medicine, vol. 16, no. 24, pp. 40–41, 2009. View at Google Scholar
  27. M. Z. Long, J. Wang, D. B. Wang, R. Chen, and M. Hong, “Clinical study on angina treated with Tong-Xin-Luo capsule,” Chinese Journal of Integrative Traditional and Western Medicine in Intensive and Critical Care, vol. 7, no. 5, pp. 270–272, 2000. View at Google Scholar
  28. Y. Wu and Z. Cui, “A 40 cases study of Shu-Xue-Tong for unstable angina,” Chinese Archives of Traditional Chinese Medicine, vol. 19, no. 5, 2001. View at Google Scholar
  29. G. M. Xiao, G. L. Yuan, X. Y. Liu, and Z. H. Shi, “Low dose of warfarin combined with Xue-Zhi-Kang for unstable angina,” The Journal of Practical Medicine, vol. 14, no. 4, pp. 270–271, 2001. View at Google Scholar
  30. B. Deng, “A 35 cases study of Zi-Ni-Guan-Xin-Tong-Tang for prevention and treatment of unstable angina,” Liaoning Journal of Traditional Chinese Medicine, vol. 29, no. 2, p. 90, 2002. View at Google Scholar
  31. G. Yang, “A 150 cases clinical obersvational study of Ru-Xin-An Capsual for unsatble angina,” Chinese Journal of the Practical Chinese With Modern Medicine, vol. 15, no. 6, p. 620, 2002. View at Google Scholar
  32. J. Zhao, “A clinical obervational study of Xue-Sai-Tong for unstable angina,” Journal of Qiqihar University of Medicine, vol. 23, no. 9, pp. 998–999, 2002. View at Google Scholar
  33. J. Gao, J. Sun, H. Su, and T. Xiao, “Clinical observation of unstable angnia treated by xintong oral solution,” Journal of Emergency in Traditional Chinese Medicine, vol. 12, no. 2, pp. 99–100, 2003. View at Google Scholar
  34. Y. Hong, P. Ren, and Y. Zhang, “Effects of Fufang Danshen Diwan on blood viscosity and serum-lipid of patient with unstable angina pectoris,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 12, no. 1, pp. 3–5, 2003. View at Google Scholar
  35. F. Nian, “Effect of Tongxinluo capsule on 30 unstable angina cases,” Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, vol. 1, no. 4, p. 244, 2003. View at Google Scholar
  36. Y. Zhang and Y. Hong, “Clinical research on patients with coronary heart disease treated by fuFang DanShen diwan,” Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine, vol. 3, no. 6, pp. 3–4, 2003. View at Google Scholar
  37. Y. Chen, “Clinical observation of Shexiang Baoxin pills for the treatment of spontaneous angina in coronary heart disease patients,” Journal of Emergency in Traditional Chinese Medicine, vol. 13, no. 12, pp. 797–798, 2004. View at Google Scholar
  38. Y. Chen, X. Tang, and L. Wang, “Effect of Acanthopanax as supplementary treatment for unstable angina patients,” People’s Military Surgeon, vol. 48, no. 7, pp. 378–380, 2005. View at Google Scholar
  39. J. Peng, “Clinical analysis of the 999 Shuxuening injection for the treatment of 46 patients with unstable angina,” Chinese Journal of the Practical Chinese with Modern Medical, vol. 18, no. 9, p. 1288, 2005. View at Google Scholar
  40. X. Liu and L. Wang, “Effect of Tongxinluo for the treatment of unstable angina,” Medical Journal of ChineSe People’S Health, vol. 18, no. 8, pp. 701–702, 2006. View at Google Scholar
  41. H. Yuan, Y. Hong, and X. Hu, “Effect of Shuxuening injection on TXB2 and 6-keto-PGF1ain senile unstable angina pectoris,” Medical Journal of the Chinese People’s Armed Police Forces, vol. 17, no. 10, pp. 746–748, 2006. View at Google Scholar
  42. H. Ning, F. K. Tang, N. W. Xi, L. Wong, and Q. Di, “Clinical study on therapeutic effect of tanshinone IIA sulfonic sodium combined with low molecular heparin against unstable angina,” Chinese Journal of Scientific and Technical Periodicals, vol. 18, pp. 195–198, 2007. View at Google Scholar
  43. J. H. Ma, W. P. Xiong, F. Wan, and M. Hua, “Study on treatment effect of tanshinone IIA sulfonic sodium combined with Xinkang on unstable angina,” China Modern Doctor, vol. 45, p. 97, 2007. View at Google Scholar
  44. S. M. Xiao, “Clinical observation on treatment with herbal formula Caihuxianxiong for unstable angina,” Chinese Journal of Integrated Medicine on Cardio/Cerebrovascular Disease, vol. 5, pp. 806–808, 2007. View at Google Scholar
  45. X. Z. Yang, Y. Q. Zhang, and H. L. Qian, “Clinical observation on tonifying deficiency and removing stasis therapy on elderly people with unstable angina,” Liao Ning Journal of Traditional Chinese Medicine, vol. 34, p. 605, 2007. View at Google Scholar
  46. M. S. Cai and Y. Q. Wei, “Study on danshen freeze-dried powder combined with low molecular heparin injection in treatment of unstable angina,” Internal Medicine of China, vol. 3, pp. 831–833, 2008. View at Google Scholar
  47. Y. Cai, “Clinical observation on therapeutic effect of puerarin on unstable angina,” Central Plains Medical Journal, vol. 35, p. 90, 2008. View at Google Scholar
  48. W. L. Chen and J. R. Fan, “Clinical Study of the formula with Soothing the liver reduce phlegm and absorb clots methods on patients with unstable angina pectoris,” Chinese Archives of Traditional Chinese Medicine, vol. 26, pp. 2209–2211, 2008. View at Google Scholar
  49. J. L. Liu, “Therapeutic effect of puerarin on angina,” China Medical Herald, vol. 5, pp. 102–103, 2008. View at Google Scholar
  50. Y. Zhang and G. Chen, “Influences of Tongxinluo on endothelin level and its efficacy in patients with unstable angina pectoris,” Chinese Medicine Modern Distance Education of China, vol. 6, no. 5, p. 441, 2008. View at Google Scholar
  51. Y. Cai and A. Wang, “Efficacy of integrated Chinese and western medicines for angina pectoris,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 18, no. 32, pp. 3959–3960, 2009. View at Google Scholar
  52. X. Chen and M. Ye, “Efficacy of Dengzhanshengmai Capsule for unstable angina pectoris,” Chinese Journal of Ethnomedicine and Ethnopharmacy, vol. 18, no. 22, p. 40, 2009. View at Google Scholar
  53. L. Su, B. Liu, X. Chen et al., “Danhong injection in treating 60 elderly patients with unstable angina,” Journal of Traditional Chinese Medicine, vol. 50, no. 3, p. 247, 2009. View at Google Scholar
  54. P. Wang, “Efficacy of Puerarin for unstable angina pectoris,” Chinese Journal of Misdiagnostics, vol. 9, no. 25, pp. 6123–6124, 2009. View at Google Scholar
  55. S. Wang, Y. Zhang, J. Yin, and D. Liu, “Efficacy of Shuxuetong injection for unstable angina pectoris,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 18, no. 19, pp. 2261–2262, 2009. View at Google Scholar
  56. N. Yu and L. Chen, “Efficacy of Tongxinluo in treating 68 patients with unstable angina pectoris,” China Modern Medicine, vol. 16, no. 13, pp. 104–105, 2009. View at Google Scholar
  57. Q.-Y. He, J. Wang, Y.-L. Zhang, Y.-L. Tang, F.-Y. Chu, and X.-J. Xiong, “Effect of Yiqi Yangyin decoction on the quality of life of patients with unstable angina pectoris,” Chinese Journal of Integrative Medicine, vol. 16, no. 1, pp. 13–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Wu and Q. Li, “Effect of Tongxinluo capsule on angina pectoris based on observation of 123 cases,” Journal of Handan Medical College, vol. 118, no. 2, pp. 114–115, 2005. View at Google Scholar
  59. Q. Li, Y. Wu, Q. Li, and H. Shi, “Observational study of the effect of Quyuningxin capsule on angina pectoris,” Journal of Emergency in Traditional Chinese Medicine, vol. 17, no. 12, pp. 1658–1659, 2008. View at Google Scholar
  60. M. Dong, “Effect of combined Shexiangbaoxin pill and isosorbide dinitrate on coronary heart disease,” Guangming Journal of Chinese Medicine, vol. 23, no. 12, pp. 1985–1986, 2008. View at Google Scholar
  61. H. Shi and Q. Shi, “Influence of compound Danshen Dropping pill on total ischemia burden and heart rate variability in Angina pectoris of coronary disease,” Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, vol. 7, no. 6, pp. 649–651, 2009. View at Google Scholar
  62. K. Shi and Y. Jiang, “Clinical study on the therapeutic effect and safety of combined atorvastatin and tongxinluo capsule in treating patients with coronary heart disease,” Journal of Sichuan of Traditional Chinese Medicine, vol. 27, no. 4, pp. 61–63, 2009. View at Google Scholar
  63. M. Lin and J. Wu, “Clinical analysis of Compound Danshen Drop pill in the treatment of 78 cases of senile coronary artery disease angina,” China Medical Herald, vol. 7, no. 7, pp. 52–53, 2010. View at Google Scholar
  64. J. Luo and H. Xu, “Outcome measures of chinese herbal medicine for coronary heart disease: an overview of systematic reviews,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 927392, 2012. View at Google Scholar
  65. K. J. Li, “A systematic review on randomized controlled trials for treatment of unstable angina pectoris with Danshen preparation,” Guangming Journal of Chinese Medicine, vol. 22, no. 2, pp. 37–40, 2008. View at Google Scholar
  66. K. J. Li, “A systematic review on randomized controlled trials for treatment of stable angina pectoris with Danshen preparations,” Herald of Medicine, vol. 26, no. 4, pp. 383–386, 2007. View at Google Scholar
  67. W. Cao, D. Lan, T. Zhang, C. Tang, T.-X. Wu, and G.-J. Liu, “Effect of Dengzhanhua Injection for angina pectoris: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 5, no. 4, pp. 317–322, 2005. View at Google Scholar · View at Scopus
  68. Y.-L. Jia, S.-K. Zhang, F.-F. Bao, F.-Y. Huang, and S.-W. Leung, “Indirect comparison of tongxinluo capsule and danshen dripping pill for angina pectoris: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 11, no. 8, pp. 919–931, 2011. View at Google Scholar · View at Scopus
  69. T. Wu, R. A. Harrison, X. Chen et al., “Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD004474, 2006. View at Google Scholar · View at Scopus
  70. X. Y. Li, F. Du, W. L. Cheng, and H. Xia, “Systematic review on randomized controlled trials for treatment of unstable angina pectoris by Shuxuetong,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 19, no. 18, pp. 2231–2233, 2010. View at Google Scholar
  71. Y. Zha and L. Li, “Systematic evaluation of yinxing dam injection in the treatment of angina pectoris,” China Pharmacy, vol. 21, no. 44, pp. 4143–4147, 2010. View at Google Scholar
  72. W. Zhao, J. S. Xiang, and K. Ye, “Systematic review on randomized controlled trials for treatment of UAP by Ginkgo extract,” Journal of Liaoning University of Traditional Chinese Medicine Pharmacology and Clinical Practice, vol. 12, no. 11, pp. 216–220, 2010. View at Google Scholar
  73. J. H. Zhang, H. C. Shang, X. M. Gao et al., “Compound salvia droplet pill, a traditional Chinese medicine, for the treatment of unstable angina pectoris: a systematic review,” Medical Science Monitor, vol. 14, no. 1, pp. RA1–RA7, 2008. View at Google Scholar · View at Scopus
  74. S. Y. Jiang, J. C. Tong, R. Y. Shun, and H. T. Xie, “Meta-analysis of compound salvia pellet for coronary angina pectoris,” Practical Pharmacy and Clinical Remedies, vol. 10, no. 6, pp. 334–337, 2007. View at Google Scholar
  75. G. H. Guyatt, A. D. Oxman, G. E. Vist et al., “GRADE: an emerging consensus on rating quality of evidence and strength of recommendations,” British Medical Journal, vol. 336, no. 7650, pp. 924–926, 2008. View at Google Scholar · View at Scopus